James LaBelle
Director, Pediatric Stem Cell and Cellular Therapy Program · University of Chicago Medical Center
Credentials: · · · · ·
History
- Present
Pediatric Hematology-Oncology and Stem Cell Transplantation Section · Pritzker School of Medicine
- Present
- 2003–2006
- 1999–2003
Research
Self-assembling peptide-based building blocks in medical applications
Review · Advanced Drug Delivery Reviews · 2017 · 172 citations
A stapled BIM peptide overcomes apoptotic resistance in hematologic cancers
Journal of Clinical Investigation · 2012 · First of 11 authors · 146 citations
CRISPR-Cas9 Editing of the HBG1 and HBG2 Promoters to Treat Sickle Cell Disease
New England Journal of Medicine · 2023 · Last of 22 authors · 140 citations
9 papers · 1 as a resident
7 papers
7 papers
7 papers
6 papers · 1 as a fellow
5 papers
5 papers
5 papers
Grants
- 2026–2031
Reprograming T Cell Function Through BCL-2 Family Protein:protein Disruption
National Cancer Institute · R01
Contact PI · $588.3K · University of Chicago
- 2011–2016
Pathologic BIM Suppression & Pharmacologic BH3 Replacement in B-Cell Lymphoma
National Cancer Institute · K08
Contact PI · $842.3K · University of Chicago
Clinical trials
- 2024–2030
Site PI · Recruiting
University of Rochester
- 2022–2028
Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis
Site PI · Recruiting · Phase 2
Boston Children's Hospital
- 2011–2041
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Site PI · Recruiting
Center for International Blood and Marrow Transplant Research